Skip to content
thispeptide

Gide Health

Gide lists compounded GLP-1 treatment and several longevity preparations. Inconsistent ingredient and administration text makes a precise prescription discussion essential before choosing a product.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

Ask the clinician to identify the drug, route and dosing instructions in writing. A drops page describing injection administration should not be used as a patient’s treatment guide.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Gide offers online assessment, clinical review and pharmacy delivery. Its homepage names compounded semaglutide and tirzepatide, plus sermorelin, NAD and glutathione in several forms. Some hormone services are labeled coming soon and should not be assumed available. A broad menu is not a substitute for the exact prescription, concentration and intended route.

What Gide Health prescribes, by goal

Weight

  • SemaglutideFDA-approved

    Listed by the seller; no price we hold.

    • TirzepatideFDA-approved

      Listed by the seller; no price we hold.

      The oral-drops page names semaglutide but includes a FAQ describing once-weekly injections. Its promoted weight-loss percentages do not establish outcomes for that oral preparation. The advanced-injection page also mixes a dual-pathway description with a semaglutide label. Obtain the actual ingredient, formulation and dosing plan from the treating clinician.

      Longevity

      • NAD+Compounding conditions apply

        Listed by the seller; no price we hold.

        • GlutathioneCompounding conditions apply

          Listed by the seller; no price we hold.

          The menu lists injection and non-injection longevity preparations. A shared ingredient name does not establish equivalent absorption or outcomes across routes. Ask what evidence supports the exact prescription and how benefit will be assessed.

          Recovery

          • SermorelinCompounding conditions apply

            Listed by the seller; no price we hold.

            Sleep

            • SermorelinCompounding conditions apply

              Listed by the seller; no price we hold.

              Who prescribes

              A licensed clinician

              The legal terms identify Beluga as a clinical network partner. Product pages quote Asad Niazi, MD, but do not establish that he is the clinician assigned to every patient. Ask which professional and practice review your history. The public treatment pages refer to affiliated compounding pharmacies without identifying the actual dispensing facility. Obtain the pharmacy name and address before treatment.

              A short online assessment precedes clinician review and an individualized decision. Approved medication is prepared and shipped, with ongoing support from the care team. The public process does not establish a fixed follow-up interval or one guaranteed visit format. Ask whether messaging reaches the prescriber and when a new clinical consultation is required. The terms also exclude care in Mississippi, New Mexico and Louisiana.

              Are labs required?

              Not mentioned

              The public care description does not establish one included laboratory panel or monitoring schedule. Ask whether baseline results are required, who orders and interprets them and whether repeat testing costs extra. A personalized-treatment claim does not itself establish how abnormal findings or adverse effects are managed.

              Ready to start with Gide Health?

              Prices and plans are set on the seller's own site.

              What it claims, and what it cites

              The homepage repeats the same generic testimonial name across different outcome statements. That presentation does not establish a documented patient cohort or typical results. Product pages also use broad weight-loss and neurologic-benefit language without establishing those outcomes for the offered preparation. Ask for evidence tied to the actual formulation rather than relying on a percentage, testimonial or broad clinical label.

              Other products and treatment claims

              Tesamorelin
              Approved only as Egrifta, for excess abdominal fat in adults with HIV-associated lipodystrophy. Its label says it is not indicated for weight loss. Egrifta became a biologic (BLA) on March 23, 2020, and FDA says compounded versions of these products do not qualify for the 503A or 503B compounding exemptions.
              Hormone services marked coming soon
              A future service label is not evidence of a currently available prescription pathway.

              How it bills

              The catalog uses starting amounts and starred monthly figures without one clearly established supplied quantity or recurring term across preparations. Do not carry an injection figure onto drops or a different product. The terms restrict refunds after services begin or a prescription is sent to the pharmacy. Obtain the selected preparation, clinical agreement and payment schedule before proceeding.

              For and against

              • For: Clinical network partner identified in terms
              • For: Provider review required before shipment
              • For: Multiple preparation types listed separately
              • For: Excluded treatment states disclosed publicly
              • Against: Ingredient and administration text conflicts
              • Against: Assigned professional still needs confirmation
              • Against: Actual dispensing pharmacy not identified
              • Against: Follow-up interval and testing costs unclear

              The evidence behind what it sells

              Right for

              Someone willing to resolve the preparation and clinical arrangements before choosing an online treatment.

              Look elsewhere if

              Someone expecting a product page’s percentage or copied administration FAQ to establish the correct individual treatment.

              Other sellers for weight

              Gide Health

              Frequently asked questions

              Does the drops page provide consistent administration instructions?
              Its main description discusses oral drops, while its FAQ discusses weekly injections. Obtain instructions for the actual prescribed preparation.
              Is the quoted doctor necessarily my prescriber?
              The public page does not establish that. Confirm the assigned clinician and clinical practice.
              Are all services available in every state?
              The terms explicitly exclude Mississippi, New Mexico and Louisiana. Confirm your location and the selected treatment.

              Sources

              • Current care process and product menu
              • Clinical network, excluded states and refund terms
              • Oral-drops description and conflicting administration FAQ
              • Standard injection description
              • Advanced injection description

              See what Gide Health prescribes today

              Gide Health sets its own prices, plans and the states it serves. Check them before you start.

              Written by Molly Ward from Gide Health’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.